CCAL
HRMY icon

City Center Advisors LLC’s Harmony Biosciences HRMY Stock Holding History

City Center Advisors LLC’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$360K Sell
9,182
-443
-5% -$17.1K 0.28% 106
2026
Q2 		$350K Buy
9,625
+939
+11% +$29.6K 0.28% 113
2026
Q1 		$243K Sell
8,686
-2,723
-24% -$89.3K 0.22% 135
2025
Q4 		$427K Buy
11,409
+3,397
+42% +$112K 0.39% 76
2025
Q3 		$221K Buy
+8,012
New +$276K 0.21% 147
2024
Q3 		– Sell
-8,773
Closed -$295K – 174
2024
Q2 		$295K Hold
8,773
– – 0.35% 116
2024
Q1 		$295K Buy
+8,773
New +$282K 0.35% 116

Other funds holding HRMY

CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

City Center Advisors LLC's HRMY Position: Q3 2026 in Review

City Center Advisors LLC reduced its Harmony Biosciences (HRMY) stake by 4.6% in Q3 2026, selling an estimated $17.1K and leaving 9,182 shares worth $360K. The position accounts for 0.28% of the portfolio, ranked #106.

City Center Advisors LLC first reported a position in HRMY in Q1 2024 and has held it in 7 quarters since. The position peaked at $427K in Q4 2025. 9 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • City Center Advisors LLC held 9,182 shares of Harmony Biosciences worth $360K as of Q3 2026.
  • City Center Advisors LLC sold 443 Harmony Biosciences shares in Q3 2026, an estimated $17.1K.
  • Harmony Biosciences made up 0.28% of City Center Advisors LLC's portfolio in Q3 2026, its #106 holding.
  • City Center Advisors LLC first reported a position in Harmony Biosciences in Q1 2024 and has held it in 7 quarters since.
  • City Center Advisors LLC's Harmony Biosciences position peaked at $427K in Q4 2025.
  • 9 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on City Center Advisors LLC's 13F filing for Q3 2026, filed 8 Oct 2026.